Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Trouw

Showing results (61-70 of 283) with videos related to

Pageof 29
Sort By:
Rheumatology (Oxford, England)|February 13, 2019
Screening for two or three autoantibodies in persons at risk for RA: implications of current data for clinical practiceRobin M Ten Brinck, Leendert A Trouw, Annette H M van der Helm-van Mil
The Journal of Hygiene|December 1, 1980
Epidemiology of mumps in the NetherlandsJ H Wagenvoort, M Harmsen, B J Boutahar-Trouw, et al.
Physical Review Letters|June 4, 2008
Local lattice dynamics and the origin of the relaxor ferroelectric behaviorW Dmowski, S B Vakhrushev, I-K Jeong, et al.
Infection and Immunity|June 13, 2001
Synthetic polysaccharide type 3-related di-, tri-, and tetrasaccharide-CRM(197) conjugates induce protection against Streptococcus pneumoniae type 3 in miceB Benaissa-Trouw, D J Lefeber, J P Kamerling, et al.
Infection and Immunity|March 1, 1996
Enhanced protection by use of a combination of anticapsule and antilipopolysaccharide monoclonal antibodies against lethal Escherichia coli O18K5 infection of miceH Frasa, B Benaissa-Trouw, L Tavares, et al.
Antiviral Research|September 1, 1983
Effect of the adjuvant dimethyl dioctadecyl ammonium bromide on the humoral and cellular immune responses to encephalomyocarditis virusC A Kraaijeveld, G la Rivière, B J Benaissa-Trouw, et al.
Lancet (London, England)|August 28, 2015
Association of anti-carbamylated protein antibodies with long-term disability and increased disease activity in patients with early inflammatory arthritis: results from the Norfolk Arthritis RegisterJennifer Humphreys, Marije Verheul, Anne Barton, et al.
Current Opinion in Immunology|October 30, 2025
Local complement inhibition by selective precision-targeted therapiesHaiyu Wang, Daan J van den Brink, Balthasar A Heesters, et al.
Journal of Virology|October 1, 1993
Influence of epitope polarity and adjuvants on the immunogenicity and efficacy of a synthetic peptide vaccine against Semliki Forest virusI M Fernández, A Snijders, B J Benaissa-Trouw, et al.
Journal of Virology|May 1, 1985
Mechanisms of monoclonal antibody-mediated protection against virulent Semliki Forest virusW A Boere, B J Benaissa-Trouw, T Harmsen, et al.
Pageof 29

Showing results (61-70 of 283) with videos related to

Sort By:
Pageof 29
Rheumatology (Oxford, England)|February 13, 2019
Screening for two or three autoantibodies in persons at risk for RA: implications of current data for clinical practiceRobin M Ten Brinck, Leendert A Trouw, Annette H M van der Helm-van Mil
The Journal of Hygiene|December 1, 1980
Epidemiology of mumps in the NetherlandsJ H Wagenvoort, M Harmsen, B J Boutahar-Trouw, et al.
Physical Review Letters|June 4, 2008
Local lattice dynamics and the origin of the relaxor ferroelectric behaviorW Dmowski, S B Vakhrushev, I-K Jeong, et al.
Infection and Immunity|June 13, 2001
Synthetic polysaccharide type 3-related di-, tri-, and tetrasaccharide-CRM(197) conjugates induce protection against Streptococcus pneumoniae type 3 in miceB Benaissa-Trouw, D J Lefeber, J P Kamerling, et al.
Infection and Immunity|March 1, 1996
Enhanced protection by use of a combination of anticapsule and antilipopolysaccharide monoclonal antibodies against lethal Escherichia coli O18K5 infection of miceH Frasa, B Benaissa-Trouw, L Tavares, et al.
Antiviral Research|September 1, 1983
Effect of the adjuvant dimethyl dioctadecyl ammonium bromide on the humoral and cellular immune responses to encephalomyocarditis virusC A Kraaijeveld, G la Rivière, B J Benaissa-Trouw, et al.
Lancet (London, England)|August 28, 2015
Association of anti-carbamylated protein antibodies with long-term disability and increased disease activity in patients with early inflammatory arthritis: results from the Norfolk Arthritis RegisterJennifer Humphreys, Marije Verheul, Anne Barton, et al.
Current Opinion in Immunology|October 30, 2025
Local complement inhibition by selective precision-targeted therapiesHaiyu Wang, Daan J van den Brink, Balthasar A Heesters, et al.
Journal of Virology|October 1, 1993
Influence of epitope polarity and adjuvants on the immunogenicity and efficacy of a synthetic peptide vaccine against Semliki Forest virusI M Fernández, A Snijders, B J Benaissa-Trouw, et al.
Journal of Virology|May 1, 1985
Mechanisms of monoclonal antibody-mediated protection against virulent Semliki Forest virusW A Boere, B J Benaissa-Trouw, T Harmsen, et al.
Pageof 29